Dr. Lal PathLabs Ltd
The live share price of Dr. Lal PathLabs Ltd (LALPATHLAB) as on 19 Apr 10:17am is ₹2,209.2 from NSE/BSE.
LALPATHLAB NSE
₹2,209.2 ▼-1.58% (-35.4)
As on Apr 19, 2024 03:47 PM IST
Key Metrics
PE Ratio
58.65
PB Ratio
11.38
Dividend Yield
0.26%
Sector PB
5.9
Sector PE
51.76
Sector Div Yld
0.56%
Dividend Yield
Dividend per share for the most recent financial year divided by the close price
About
Dr Lal Pathlabs Private Limited is headquartered in Gurgaon, Haryana, India and is a medical laboratory operator.
The following charts display the financial performance of the Dr. Lal PathLabs Ltd (LALPATHLAB) stock, including the year-on-year Income Statement , Balance Sheet , Cash Flow Statement and Shareholding pattern.
Furthermore, under the Peers section, you can find stocks that are similar to Dr. Lal PathLabs Ltd (LALPATHLAB), and their live stock price and performance at a glance. Click on any peer stock to navigate to that stock’s live price page.
✅ If you’re new to investing in the stock market, and/or are unsure about your investment options, you can explore smallcases.
A smallcase is a readymade stock/ETF portfolio (also known as a stock basket) that is based on an investment idea, theme or strategy. Examples of popular smallcases include All Weather Investing , Equity and Gold , Top 100 Stocks , Green Energy and Value & Momentum.
All smallcases are created and managed by SEBI-registered investment experts.
To invest in smallcases, all you need is a demat/trading account. You retain complete ownership of the smallcase’s constituent stocks or ETFs, as they are directly credited to your broking account. You can choose from over 500+ smallcases across 180+ smallcase managers to start your investment journey.
Financials
Income Statement
(INR) | Y/Y Change | |
Revenue | 2,058 Cr | -3.8% |
Operating Expense | 407 Cr | +6.17% |
Net Income | 238 Cr | -30.74% |
Net Profit Margin | 11.6% | -28% |
Earning Per Share | 28 | -30.76% |
EBITDA | 531 Cr | -13.33% |
Balance sheet
(INR) | Y/Y Change | |
Cash & short-term Inv | 815 Cr | +19.37% |
Total Assets | 2,382 Cr | +1.7% |
Total Liabilities | 683 Cr | -15.2% |
Total Equity | 1,699 Cr | +10.56% |
Shares Outstanding | 8.34 Cr | +0.07% |
Price to Book | 8.97 | -36.31% |
Return on Assets | 10.11% | -41.32% |
Return on Capital | 22.44 Cr | -31.71% |
Cash Flows
(INR) | Y/Y Change | |
Net Income | 238 Cr | -30.74% |
Cash from Operations | 456 Cr | +2.09% |
Cash from Investing | -287 Cr | -36.05% |
Cash from Financing | -283 Cr | -307.53% |
Net Change in Cash | -114 Cr | -185.49% |
Free Cash Flow | 411 Cr | -1497.15% |
Peers
APOLLOHOSP
Apollo Hospitals Enterprise Ltd
PE Ratio
115.4
1Y Return
▲42.8%
MAXHEALTH
Max Healthcare Institute Ltd
PE Ratio
75.21
1Y Return
▲67.73%
MEDANTA
Global Health Ltd
PE Ratio
82.39
1Y Return
▲175.28%
FORTIS
Fortis Healthcare Ltd
PE Ratio
60.25
1Y Return
▲64.73%
Latest News
Trade setup for Thursday: 15 things to know before opening bell
2 days ago on Moneycontrol
Change since news ▼-INF%
Based on the OI percentage, a total of 44 stocks were on the short-covering list which included Exide Industries, Coromandel International, Mahanagar Gas, Birlasoft, and Dr Lal PathLabs.
Dr Lal PathLabs jumps 5% on double upgrade from Kotak Institutional Equities
4 weeks ago on Moneycontrol
Change since news ▼-INF%
Dr Lal PathLabs shares were trading at Rs 2,234.65, up nearly 5 percent from the previous close. The revised price target implies an upside of 8 percent from March 22 closing
Trade setup for Tuesday: 15 things to know before opening bell
1 month ago on Moneycontrol
Change since news ▼-INF%
A short build-up was seen in 70 stocks, including Coforge, Dr Lal PathLabs, Apollo Tyres, Adani Ports & Special Economic Zone and Adani Enterprises
FAQs on Dr. Lal PathLabs Ltd
How to buy Dr. Lal PathLabs Ltd stocks?
You can easily buy the stocks/shares of Dr. Lal PathLabs Ltd (LALPATHLAB) through either a broker or a financial institution by opening a Demat & Trading account online via smallcase.
What is the Share Price of Dr. Lal PathLabs Ltd?
The stock price of Dr. Lal PathLabs Ltd as on 19 Apr 2024 is ₹2,209.2
What is the 52-week High and Low of Dr. Lal PathLabs Ltd?
The 52-week high and low of Dr. Lal PathLabs Ltd (LALPATHLAB) is ₹2,767.1 and ₹1,872.55.
What is the PE and PB ratio of Dr. Lal PathLabs Ltd?
The P/E (price-to-earnings) and P/B (price-to-book) ratios of Dr. Lal PathLabs Ltd are 58.65 and 11.38 respectively.
What are the peers or stocks similar to Dr. Lal PathLabs Ltd?
The peers or stocks similar to Dr. Lal PathLabs Ltd are Apollo Hospitals Enterprise Ltd, Max Healthcare Institute Ltd, Global Health Ltd, Fortis Healthcare Ltd and many others. smallcase also offers over 200 readymade stock baskets managed by 180+ SEBI-registered investment experts. These stock portfolios are based on a theme, idea or strategy. You can use smallcase to start investing in diversified stock baskets.
Which sector does Dr. Lal PathLabs Ltd belong to?
Dr. Lal PathLabs Ltd (LALPATHLAB) belongs to the Hospitals & Diagnostic Centres sector.
What is the Market Cap of Dr. Lal PathLabs Ltd?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Dr. Lal PathLabs Ltd (LALPATHLAB) is ₹19,348 Cr as of 19 Apr 2024
Can't decide whether or not to buy Dr. Lal PathLabs Ltd stocks? ⭐️
Worry no more! smallcase offers readymade stock baskets/portfolios that are based on an theme, idea or strategy. You can choose from more than 500+ stock portfolios managed by 180+ SEBI-registered investment experts.